Doctor profile · Federal record
Dr. Shuo Ma, M.D., PH.D.
Hematology & Oncology Physician (CMS: Hematology) · Chicago, IL
- NPI 1659564938
- Accepts Medicare
- MIPS 91.3 / 100 · 2023
- 32 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
676 N Saint Clair St, Suite 850
Chicago, IL 606112927
(312) 695-6180
fax (312) 695-6189
Credentials & registration
- NPI registered
- August 2007 — 19 yrs on file
- Year of graduation
- 1994 — 32 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1659564938. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
59,158
Distinct HCPCS
10
Medicare allowed
$1,698,206
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 9,090 | 35 | $48 | |
J1439 |
Injection, ferric carboxymaltose, 1 mg | 8,000 | 11 | $1 | |
J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 6,280 | 65 | $45 | |
J1453 |
Injection, fosaprepitant, 1 mg | 6,150 | 34 | $0 | |
J9299 |
Injection, nivolumab, 1 mg | 5,900 | 13 | $30 | |
J1756 |
Injection, iron sucrose, 1 mg | 3,500 | 12 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 3,400 | 15 | $54 | |
Q5119 |
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 3,285 | 25 | $26 | |
J9047 |
Injection, carfilzomib, 1 mg | 2,218 | 13 | $45 | |
J0897 |
Injection, denosumab, 1 mg | 2,100 | 17 | $23 |
In context: peer comparison
Among 77 peers in this city , average services per provider: 870. This provider delivers 68× the peer median.Open Payments
Industry payments received
All-time total
$44,650
Transactions
41
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $17,317.31 | |
| Lilly USA, LLC | 5 | $11,200.00 | |
| BeiGene USA, Inc. | 4 | $11,000.00 | |
| ABBVIE INC. | 9 | $2,982.84 | |
| Invivyd Inc | 1 | $2,100.00 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $49.95 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
657
Patients
145
Total drug cost
$2,816,951
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Acyclovir | Generic | 359 | 102 | $6,834 |
| Calquence (Acalabrutinib Maleate) | Brand | 104 | 16 | $1,596,908 |
| Brukinsa (Zanubrutinib) | Brand | 44 | 0 | $607,671 |
| Allopurinol | Generic | 36 | 13 | $480 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 24 | 0 | $1,429 |
| Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) | Brand | 19 | 0 | $147 |
| Paxlovid (Eua) (Nirmatrelvir/Ritonavir) | Brand | 17 | 14 | $155 |
| Entecavir | Generic | 15 | 0 | $3,984 |
| Venclexta (Venetoclax) | Brand | 15 | 0 | $232,680 |
| Imbruvica (Ibrutinib) | Brand | 13 | 0 | $219,179 |
Hospital affiliations
Frequently asked questions
What is Dr. Shuo Ma's medical specialty?
Dr. Shuo Ma practices Hematology & Oncology Physician in Chicago, IL.
Where does Dr. Shuo Ma practice?
Dr. Shuo Ma practices at 676 N Saint Clair St, Chicago, IL 606112927. Office phone: 3126956180.
What is Dr. Shuo Ma's NPI?
Dr. Shuo Ma's National Provider Identifier (NPI) is 1659564938, issued by NPPES.
Does Dr. Shuo Ma accept Medicare assignment?
Yes. Dr. Shuo Ma accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Shuo Ma commonly perform?
Top Medicare-reported procedures in 2023: Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144); Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS J1569). Source: CMS Medicare Physician & Other Practitioners file.